- ►oxfordjournals.org DS Silverberg, D Wexler, M Blum, JZ … - Nephrology Dialysis Transplantation, 2003 - ERA-EDTA Results. With the Epo-Fe treatment the Hb increased from 10.41±1.0 to 13.1±1.3
g% in diabetics and from 10.5±1.0 to 12.9±1.2 g% in non-diabetics. Comparing
the diabetics and non-diabetics, the New York Heart Association functional ... Cited by 220 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org JL Gross, MJ de Azevedo, SP Silveiro, LH … - Diabetes Care, 2005 - Am Diabetes Assoc Diabetic nephropathy is the leading cause of kidney disease in patients starting
renal replacement therapy and affects ∼40% of type 1 and type 2 diabetic
patients. It increases the risk of death, mainly from cardiovascular ... Cited by 214 - Related articles - All 18 versions
- ►93-octane.com [PDF] - Free from Publisher MC Thomas, RJ MacIsaac, C Tsalamandris, D … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—A total of 190 patients (23%) had unrecognized anemia (Hb <12 g/dl for
women and <13 g/dl for men). This prevalence is two to three times higher than
for patients with comparable renal impairment and iron stores in the ... Cited by 89 - Related articles - BL Direct - All 7 versions
R Dikow, V Schwenger, M Schomig, E Ritz - Nephrology Dialysis Transplantation, 2002 - ERA-EDTA Abstract Anaemia is an important component of diabetic nephropathy but only
recently has it attracted the attention of diabetologists and nephrologists. In
diabetic patients, anaemia is the result of diminished erythropoietin ... Cited by 56 - Related articles - BL Direct - All 5 versions
MC Thomas, ME Cooper, C Tsalamandris, R … - Archives of Internal Medicine, 2005 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 52 - Related articles - All 4 versions
- ►asnjournals.org PT Vlagopoulos, H Tighiouart, DE Weiner, J … - Journal of the American Society of Nephrology, 2005 - Am Soc Nephrol Anemia is a potential nontraditional risk factor for cardiovascular disease
(CVD). This study evaluated whether anemia is a risk factor for adverse outcomes
in people with diabetes and whether the risk is modified by the presence of ... Cited by 51 - Related articles - BL Direct - All 6 versions
TM El-Achkar, SE Ohmit, PA Mccullough, ED … - Kidney international, 2005 - nature.com KEEP 2.0 screening data were used to determine the prevalence of anemia by level
of kidney function and diabetes status. Estimated glomerular filtration rate
(EGFR) was calculated using serum creatinine values, and categorized as 90, ... Cited by 45 - Related articles - All 3 versions
- ►bjmu.edu.cn [PDF] MJ Renzi, FX Farrell, A Bittner, JE Galindo, M … - Molecular Brain Research, 2002 - Elsevier Erythropoietin (EPO) is the primary modulator of red blood cell production.
Recently EPO has received considerable attention for its functions outside of
hematopoiesis, including its effects in the nervous system where it has ... Cited by 39 - Related articles - All 7 versions
- ►diabetesjournals.org KJ Craig, JD Williams, SG Riley, H Smith, DR … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—The study group was comprised of 62 patients with
type 2 diabetes who had been followed for a median of 7 years. For the study,
these patients had additional samples taken during their annual routine ... Cited by 38 - Related articles - All 6 versions
KU Eckardt, A Kurtz - European Journal of Clinical Investigation, 2005 - interscience.wiley.com The glycoprotein hormone erythropoietin (EPO) is an essential growth and
survival factor for erythroid progenitor cells, and the rate of red blood cell
production is normally determined by the serum EPO concentration. EPO ... Cited by 37 - Related articles - BL Direct - All 3 versions
